<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2023.1221553</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Recognition of pseudoinvasion in colorectal adenoma using spatial glycomics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Boyaval</surname> <given-names>Fanny</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2300628/overview"/>
</contrib>
<contrib contrib-type="author"><name><surname>Fari&#x00F1;a-Sarasqueta</surname> <given-names>Arantza</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/642255/overview"/>
</contrib>
<contrib contrib-type="author"><name><surname>Boonstra</surname> <given-names>Jurjen J.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Heijs</surname> <given-names>Bram</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1353047/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Morreau</surname> <given-names>Hans</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pathology, Leiden University Medical Center</institution>, <addr-line>Leiden</addr-line>, <country>Netherlands</country></aff>
<aff id="aff2"><sup>2</sup><institution>Center for Proteomics &#x0026; Metabolomics, Leiden University Medical Center</institution>, <addr-line>Leiden</addr-line>, <country>Netherlands</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam</institution>, <addr-line>Amsterdam</addr-line>, <country>Netherlands</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Gastroenterology and Hepatology, Leiden University Medical Center</institution>, <addr-line>Leiden</addr-line>, <country>Netherlands</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Weiren Luo, The Second Affiliated hospital of Southern University of Science and Technology, China</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Antonio Palumbo, Federal University of Rio de Janeiro, Brazil; Ranran Zhang, University of Alberta, Canada</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Hans Morreau, <email>J.Morreau@lumc.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1221553</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Boyaval, Fari&#x00F1;a-Sarasqueta, Boonstra, Heijs and Morreau.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Boyaval, Fari&#x00F1;a-Sarasqueta, Boonstra, Heijs and Morreau</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Pseudoinvasion (PI) is a benign lesion in which cancer is mimicked in the colon by misplacement of dysplastic glands in the submucosa. Although there are morphological clues, the discrimination of PI from true invasion can be a challenge during pathological evaluation of colon adenomas. Both overdiagnosis and underdiagnosis can result in inadequate clinical decisions. This calls for novel tools to aid in cases where conventional methods do not suffice. We performed mass spectrometry imaging (MSI)-based spatial glycomics analysis on a cohort of formalin-fixed paraffin-embedded tissue (FFPE) material from 16 patients who underwent polypectomy. We used this spatial glycomic data to reconstruct the molecular histology of the tissue section using spatial segmentation based on uniform manifold approximation and projection for dimension reduction (UMAP). We first showed that the spatial glycomic phenotypes of the different morphological entities separated as distinct clusters in colon tissues, we separated true invasion from the other morphological entities. Then, we found that the glycomic phenotype in areas with suspected PI in the submucosa was strongly correlating with the corresponding glycomic phenotype of the adenomatous colon epithelium from the same tissue section (Pearson correlation distance average&#x2009;=&#x2009;0.18). These findings suggest that using spatial glycomics, we can distinguish PI as having a molecular phenotype similar to the corresponding surface epithelium and true invasion as having a different phenotype even when compared to high-grade dysplasia. Therefore, when a novel molecular phenotype is found in the deepest submucosal region, this may be used as an argument in favor of true invasion.</p>
</abstract>
<kwd-group>
<kwd>mass spectrometry imaging</kwd>
<kwd>colorectal cancer</kwd>
<kwd>pseudoinvasion</kwd>
<kwd>glycomic</kwd>
<kwd>marker</kwd>
</kwd-group>
<contract-num rid="cn1">6212</contract-num>
<contract-sponsor id="cn1">Leiden University Medical Center<named-content content-type="fundref-id">10.13039/501100005039</named-content></contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="16"/>
<page-count count="6"/>
<word-count count="3553"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Pathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1"><label>1</label>
<title>Introduction</title>
<p>Discrimination of so-called pseudoinvasion (PI) from true invasion is an outstanding diagnostic challenge during pathological evaluation of resected colon polyps. PI is a benign lesion in which cancer is mimicked by misplacement of dysplastic epithelium in the submucosa. PI is diagnosed pathologically after endoscopic polypectomy of colon adenomas, especially in pedunculated polyps. However, in difficult cases, the inadequate recognition of PI can lead to overdiagnosis and consequently to undesirable colonic surgical resections which can affect the quality of life of the patients (<xref ref-type="bibr" rid="ref1">1</xref>). Since the introduction of population screening, early stage colorectal lesions are far more often diagnosed than ever before (Detection at early stage 67%). To date, there is a lack of reliable statistics results that highlight the frequency of PI occurrence, however it is likely that every GI pathologist is confronted with this critical issue. Even though there are differentiating histopathological criteria available, such as the absence of a desmoplastic reaction and the presence of iron (a sign of early bleeding) in the case of PI these are not always present or evaluable. Hence, expert panels can be needed to provide trustworthy and accurate assessments (<xref ref-type="bibr" rid="ref2">2</xref>). This calls for novel, specific and sensitive tools to aid in cases where conventional methods do not suffice.</p>
<p>N-glycans, a common form of post-translational protein modification, are known to play a significant role in fundamental molecular and cellular processes involved in cancer such as tumor cell invasion, cell motility, formation of metastases, angiogenesis, and modulation of the immune response (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). In colorectal cancer, the alterations observed in the <italic>N</italic>-glycome have also demonstrated the ability to differentiate between distinct morphological subtypes of early-stage, while also displaying tumor stage specificity (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>). We have previously reported the use of mass spectrometry imaging (MSI)-based spatial glycomics analysis of formalin-fixed paraffin-embedded tissue (FFPE) to differentiate morphological entities in early colorectal cancer (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>). Here, we have applied the same strategy to demonstrate that using spatial glycomic profiling we were able to show the similarity of the glycomic phenotype in areas suspected to have PI in the submucosa and the corresponding glycomic phenotype of the adjacent colon epithelium.</p>
</sec>
<sec sec-type="materials|methods" id="sec2"><label>2</label>
<title>Materials and methods</title>
<sec id="sec3"><label>2.1</label>
<title>Tissue sample collection</title>
<p>Endoscopic polypectomy specimens (<italic>n</italic>&#x2009;=&#x2009;16) used in this study were obtained from the Department of Pathology of the Leiden University Medical Center. Tissues were formalin-fixed and paraffin-embedded (FFPE) following routine diagnostic protocols. All samples were anonymized, according to the national ethical guidelines (&#x201C;Code for Proper Secondary Use of Human Tissue,&#x201D; Dutch Federation of Medical Scientific Societies).</p>
</sec>
<sec id="sec4"><label>2.2</label>
<title>Sample preparation for spatial N-Glycomics by MALDI-MSI</title>
<p>FFPE tissues were sectioned at 6&#x2009;&#x03BC;m thickness. Deparaffinization, rehydration and sialic acid linkage-specific derivatization were performed as described previously (<xref ref-type="bibr" rid="ref8">8</xref>). Tissue enzymatic <italic>N</italic>-glycan release was performed applying 10 layers of PNGase F (0.1&#x2009;&#x03BC;g/&#x03BC;L in Tris buffer) and CHCA matrix was used (5&#x2009;mg/mL CHCA in 50:49.9/0.1 (% v/v/v) ACN:mQ:TFA).</p>
</sec>
<sec id="sec5"><label>2.3</label>
<title>Spatial glycomics and histopathological analysis</title>
<p>All specimens were mixed and measured in randomized fashion. Spatial glycomics was performed on a rapifleX MALDI-TOF/TOF-MS instrument in positive ion reflectron mode (Bruker Daltonics). Spectra were recorded using 1,000 laser shots per pixel with 50&#x2009;&#x00D7;&#x2009;50&#x2009;&#x03BC;m<sup>2</sup> pixel size (laser setting &#x201C;M5 small&#x201D;) over an <italic>m/z</italic> range of 900&#x2013;3,300. After the analysis, excess MALDI-matrix was removed, tissues were hematoxylin and eosin (H&#x0026;E) stained following routine histopathological procedures and then scanned using a digital slide scanner (IntelliSite Pathology Ultra-Fast Scanner, Philips, Eindhoven, Netherlands). In the flexImaging software, image scans and spatial glycomics data were co-registered and regions of interest (ROIs) were selected based on the histopathological analysis of the H&#x0026;E slides by expert pathologists (AFS, HM). The spatial glycomics data, co-registered H&#x0026;E images and ROIs from the whole cohort were imported into SCiLS lab software (2016b, version 4.01.8781, Bruker Daltonics).</p>
</sec>
<sec id="sec6"><label>2.4</label>
<title>Data preprocessing and statistical analysis UMAP</title>
<p>Data preprocessing were performed using the same methods as in Boyaval et al. (<xref ref-type="bibr" rid="ref8">8</xref>). Spatial segmentation using uniform manifold approximation and projection for dimension reduction (UMAP) analysis was performed on peak picked, TIC normalized single-pixel spectra, exported from SCiLS Lab for each individual tissue. UMAP was performed using the <italic>Seurat v3</italic> package in R using default parameters. Each pixel were translated to RGB colors corresponding the color of the UMAP cluster, cluster corresponding to non-cellular areas were colored as white in the main figure. Molecular histology images were reconstructed in MATLAB. The correlation-based distance measures were performed using Pearson methods in R for each single tissue between the different morphologies by using the average intensity of the ROIs. In the Pearson correlation distance, similar object close to one other have a score close to 0, the bigger the distance the higher the score.</p>
</sec>
</sec>
<sec sec-type="results" id="sec7"><label>3</label>
<title>Results and discussion</title>
<p>We performed spatial glycomics on FFPE material of 16 patients who underwent a polypectomy and reconstructed the molecular histology of the tissues using spatial segmentation based on uniform manifold approximation and projection for dimension reduction (UMAP). Molecular histology reconstruct-images were compared with the corresponding post-MSI H&#x0026;E staining to evaluate the molecular signatures of areas with suspected PI.</p>
<sec id="sec8"><label>3.1</label>
<title>Differentiation between invasive vs. non-invasive adenocarcinoma</title>
<p>To test that spatial glycomics was capable of differentiating invasive adenocarcinoma from (non-invasive) dysplastic areas in colorectal polyps, eight cases of T1 colorectal cancer (malignant polyp) were analyzed (<xref ref-type="table" rid="tab1">Table 1</xref>). In seven cases, the histological annotations of the invasive areas directly showed the expected molecular profiles. In <xref ref-type="fig" rid="fig1">Figure 1A</xref>, a representative case with invasive adenocarcinoma, high-grade, low-grade dysplasia and normal epithelium is depicted (Tissue-section 5, <xref ref-type="table" rid="tab1">Table 1</xref>). Each of these morphological entities corresponded to a specific molecular signature as shown in the molecular histology reconstruct-image in <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</p>
<table-wrap position="float" id="tab1"><label>Table 1</label>
<caption>
<p>Clinical characteristics of patient cohort for tissue with true invasion in colorectal adenocarcinoma.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Tissue true invasion</th>
<th align="center" valign="middle">1</th>
<th align="center" valign="middle">2</th>
<th align="center" valign="middle">3</th>
<th align="center" valign="middle">4</th>
<th align="center" valign="middle">5</th>
<th align="center" valign="middle">6</th>
<th align="center" valign="middle">7</th>
<th align="center" valign="middle">8</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Cancer: histological annotation</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
</tr>
<tr>
<td align="left" valign="middle">Cancer: molecular annotation</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Mucinous pool</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
</tr>
<tr>
<td align="left" valign="middle">Gender</td>
<td align="center" valign="middle">Female</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Female</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
</tr>
<tr>
<td align="left" valign="middle">Age (years)</td>
<td align="center" valign="middle">59</td>
<td align="center" valign="middle">65</td>
<td align="center" valign="middle">57</td>
<td align="center" valign="middle">67</td>
<td align="center" valign="middle">69</td>
<td align="center" valign="middle">71</td>
<td align="center" valign="middle">67</td>
<td align="center" valign="middle">71</td>
</tr>
<tr>
<td align="left" valign="middle">Tumor differentiation</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
<td align="center" valign="middle">Well/moderately</td>
</tr>
<tr>
<td align="left" valign="middle">Lymphovascular invasion</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">Yes</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">Suspicious</td>
</tr>
<tr>
<td align="left" valign="middle">Tumor budding</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">Grade 3</td>
<td align="center" valign="middle">Grade 1</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">Grade 2</td>
<td align="center" valign="middle">Grade 2</td>
<td align="center" valign="middle">No</td>
<td align="center" valign="middle">Grade 1</td>
</tr>
<tr>
<td align="left" valign="middle">Kikuchi/ Haggit level</td>
<td align="center" valign="middle">sm3</td>
<td align="center" valign="middle">sm1</td>
<td align="center" valign="middle">sm2</td>
<td align="center" valign="middle">n/a</td>
<td align="center" valign="middle">Haggit 2&#x2013;3</td>
<td align="center" valign="middle">sm2</td>
<td align="center" valign="middle">sm1</td>
<td align="center" valign="middle">sm2</td>
</tr>
<tr>
<td align="left" valign="middle">LNM (1-yes/0-no)</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">1</td>
</tr>
<tr>
<td align="left" valign="middle">Diameter (cm)</td>
<td align="center" valign="middle">1.5</td>
<td align="center" valign="middle">0.9</td>
<td align="center" valign="middle">1.2</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">0.6</td>
<td align="center" valign="middle">0.9</td>
<td align="center" valign="middle">0.7</td>
<td align="center" valign="middle">0.6</td>
</tr>
<tr>
<td align="left" valign="middle">Depth (mm)</td>
<td align="center" valign="middle">5</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">6</td>
<td align="center" valign="middle">5</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">2</td>
</tr>
<tr>
<td align="left" valign="middle">Endoscopy morphology</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Pedunculated</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Sessile</td>
</tr>
<tr>
<td align="left" valign="middle">Topography</td>
<td align="center" valign="middle">Rectosigmoid</td>
<td align="center" valign="middle">Rectosigmoid</td>
<td align="center" valign="middle">Rectum</td>
<td align="center" valign="middle">Transversal</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Rectum</td>
<td align="center" valign="middle">Sigmoid</td>
</tr>
<tr>
<td align="left" valign="middle">TNM (+/&#x2212; resection)</td>
<td align="center" valign="middle">pT0N1</td>
<td align="center" valign="middle">pT0N1(mi)M0</td>
<td align="center" valign="middle">pT0N1</td>
<td align="center" valign="middle">pT4N1</td>
<td align="center" valign="middle">pT1N0</td>
<td align="center" valign="middle">pT1 (NxMx)</td>
<td align="center" valign="middle">pT1 (NxMx)</td>
<td align="center" valign="middle">pT1 (NxMx)</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig1"><label>Figure 1</label>
<caption>
<p><bold>(A)</bold> Tissue-section 5: H&#x0026;E staining of a T1 colorectal cancer with invasive adenocarcinoma with the histological annotations on the right. <bold>(B)</bold> Molecular histology reconstruct-image of the same tissue after UMAP analysis on the spatial glycomics data with the corresponding annotations on the left. <bold>(C)</bold> Tissue 9: H&#x0026;E staining and <bold>(D)</bold> molecular histology reconstruct-image of a tissue with confirmed PI and histological annotation in the middle. <bold>(E)</bold> Zoom in (40x) on five areas in tissue <bold>C</bold>, with corresponding numbers to the areas in <bold>C</bold>. Example in E1, green line in H&#x0026;E; normal epithelium appeared as orange/blue in the molecular histology reconstruct-image. Yellow line in H&#x0026;E; pseudoinvasion appeared as grey (same as high-grade dysplasia) and as blue (same as normal epithelium) in the molecular histology reconstruct-image.</p>
</caption>
<graphic xlink:href="fmed-10-1221553-g001.tif"/>
</fig>
<p>In one case (Tissue 4, <xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1A,B</xref> and <xref ref-type="table" rid="tab1">Table 1</xref>), the molecular signature of the invasive part did not fully match the histological annotation but highlighted the presence of mucinous pools with invasive cells as a novel separate cluster in the submucosa.</p>
</sec>
<sec id="sec9"><label>3.2</label>
<title>Molecular-histology features of pseudoinvasion</title>
<p>Then a total of eight cases with suspected PI were analyzed (<xref ref-type="table" rid="tab2">Table 2</xref>). In seven cases, the morphological appearance of the suspected PI areas was similar to the one of the surface low-grade dysplasia epithelium (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1C,D</xref>). Rather than showing up as a distinct molecular phenotype, as would be expected for true invasive adenocarcinoma, the molecular histology of the suspected PI areas correlated highly with the histologically confirmed low-grade dysplasia areas in the same tissue (Pearson correlation distance&#x2009;=&#x2009;0.05; <xref ref-type="table" rid="tab2">Table 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>).</p>
<table-wrap position="float" id="tab2"><label>Table 2</label>
<caption>
<p>Clinical characteristics of patient cohort for tissue with pseudoinvasion, <italic>N</italic>&#x2009;=&#x2009;Normal epithelium; LG&#x2009;=&#x2009;low-grade dysplasia; HG&#x2009;=&#x2009;High-grade dysplasia.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Tissue Pseudoinvasion</th>
<th align="center" valign="middle">9</th>
<th align="center" valign="middle">10</th>
<th align="center" valign="middle">11</th>
<th align="center" valign="middle">12</th>
<th align="center" valign="middle">13</th>
<th align="center" valign="middle">14</th>
<th align="center" valign="middle">15</th>
<th align="center" valign="middle">16</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Pseudoinvasion: histological annotation</td>
<td align="center" valign="middle">HG &#x0026; N</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
</tr>
<tr>
<td align="left" valign="middle">Pseudoinvasion: molecular annotation</td>
<td align="center" valign="middle">HG &#x0026; N</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
<td align="center" valign="middle">LG</td>
</tr>
<tr>
<td align="left" valign="middle">Pearson correlation Distance</td>
<td align="center" valign="middle">0.01 &#x0026; 0.06</td>
<td align="center" valign="middle">0.09</td>
<td align="center" valign="middle">0.23</td>
<td align="center" valign="middle">0.05</td>
<td align="center" valign="middle">0.14</td>
<td align="center" valign="middle">0.03</td>
<td align="center" valign="middle">0.20</td>
<td align="center" valign="middle">0.22</td>
</tr>
<tr>
<td align="left" valign="middle">Gender</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">Male</td>
</tr>
<tr>
<td align="left" valign="middle">Age</td>
<td align="center" valign="middle">75</td>
<td align="center" valign="middle">62</td>
<td align="center" valign="middle">71</td>
<td align="center" valign="middle">60</td>
<td align="center" valign="middle">81</td>
<td align="center" valign="middle">60</td>
<td align="center" valign="middle">64</td>
<td align="center" valign="middle">62</td>
</tr>
<tr>
<td align="left" valign="middle">Diameter (cm)</td>
<td align="center" valign="middle">2.4</td>
<td/>
<td align="center" valign="middle">1.2</td>
<td align="center" valign="middle">1.5</td>
<td align="center" valign="middle">1.7</td>
<td align="center" valign="middle">1.7</td>
<td align="center" valign="middle">1.8</td>
<td align="center" valign="middle">2</td>
</tr>
<tr>
<td align="left" valign="middle">Endoscopy morphology</td>
<td align="center" valign="middle">Pedunculated</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Pedunculated</td>
<td align="center" valign="middle">Pedunculated</td>
<td align="center" valign="middle">Sessile</td>
<td align="center" valign="middle">Pedunculated</td>
<td align="center" valign="middle">Pedunculated</td>
<td align="center" valign="middle">Pedunculated</td>
</tr>
<tr>
<td align="left" valign="middle">Topography</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Descending</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Sigmoid</td>
<td align="center" valign="middle">Sigmoid</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In another case, in <xref ref-type="fig" rid="fig1">Figures 1C</xref>,<xref ref-type="fig" rid="fig1">E</xref> (Tissue 9, <xref ref-type="table" rid="tab2">Table 2</xref>), PI of normal and high grade dysplastic epithelium correlated thoroughly with the corresponding molecular histology in <xref ref-type="fig" rid="fig1">Figures 1D</xref>,<xref ref-type="fig" rid="fig1">E</xref> (Pearson correlation distance&#x2009;=&#x2009;0.01 &#x0026; 0.06).</p>
</sec>
<sec id="sec10"><label>3.3</label>
<title>Discussion</title>
<p>Here, the application of MALDI-MSI-based spatial glycomics has been used to address the differential diagnosis of PI from true invasive cancer.</p>
<p>Dimensionality reduction on the high-dimensional spatial glycomics data provided molecular histology. This molecular histology showed comparability to conventional histomorphology in recognizing normal and different grades of neoplastic epithelium, but it displayed enhanced discriminatory potential between PI and true invasion.</p>
<p>In this report we showed that in all analyzed cases the glycomic molecular phenotype of PI was identical to that of the corresponding surface epithelium (either high-grade dysplasia, low-grade dysplasia or normal epithelium). We also highlight that the same technology is able to detect true invasion as separate molecular phenotype even with a high correlation score with the high-grade dysplasia (Pearson correlation distance&#x2009;=&#x2009;0.26; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). Therefore, when a novel molecular phenotype is found in the deepest submucosal part, it might be used as an argument in favor of true invasion. These findings are in line with our previous studies that showed strong changes in glycomic signatures during the progression of stage I and stage II colorectal cancer (<xref ref-type="bibr" rid="ref8">8</xref>). Additionally, others have demonstrated that employing the same technique has the potential to enhance tumor classification accuracy in pancreatic, ovarian, and hepatocellular carcinoma (<xref ref-type="bibr" rid="ref9 ref10 ref11">9&#x2013;11</xref>).</p>
<p>The fact that FFPE material is suitable for the spatial glycomics platform, and that the total diagnostic time spent is comparable to most immunohistochemistry protocols (approximately 2&#x2009;days), makes this technique appropriate for running in parallel with the routine diagnostic workflow. The molecular histology reconstruct-image resulting from the spatial glycomics platform facilitates the direct comparison with H&#x0026;E and other histopathological stainings by trained pathologists. However, while the samples, sample preparation, and required reagents for these analyses are easily obtainable and manageable within most pathology departments, it&#x2019;s important to note that an imaging mass spectrometer and the expertise to operate the instrument and extract the data are necessary. The initial investment in the instrument and the requirement for specialized skills during operation should be carefully considered. For the data analysis part, once the pipeline and code are developed, it becomes user-friendly and applicable on any computer. This underscores the dual aspects of both accessibility and the requisite expertise associated with deploying this spatial glycomics platform in routine diagnostics. Nevertheless, this technique holds the potential to serve as a diagnostic tool in challenging scenarios where distinguishing between T1 colon cancer and PI is a subject of debate.</p>
<p>Clinical pathologists often pay more attention to morphological changes instead of the possible explanations behind them. Recently, an article proposed the concept of ecological pathology, stating that it is essential to apply the ecological (&#x2212;evolutionary) principles and approaches to study the etiology, pathogenesis, pathological changes and outcomes of human diseases (<xref ref-type="bibr" rid="ref12">12</xref>). For example, in this paper, tumor vascular mimicry is proposed to be an ecological adaptation. Similarly, the now discussed pseudoinvasion is a benign condition in which cancer is mixed in the colon by misplacement of dynamic lands in the submucosa, which might also be thought as an ecological adaptation due to the similar habitat.</p>
<p>This proof-of-concept study, while limited in cases, emphasizes the necessity for a more extensive cohort, particularly incorporating additional adenomas with high-grade dysplasia in the pseudoinvasion component, to validate these findings. Increasing the sample size holds the potential to significantly enhance statistical robustness, pattern generalizability, stability, and detection reliability. Such a comprehensive dataset is crucial for establishing a strong foundation, ensuring precision across cases, and minimizing the impact of variability in practically applying glycomic patterns to clinical diagnoses. While ongoing optimization of MSI analysis techniques remains valuable, and several studies have been working on it (<xref ref-type="bibr" rid="ref13 ref14 ref15 ref16">13&#x2013;16</xref>), the true strength of the separation criteria lies in the extensive representation of diverse cases through a larger sample size.</p>
<p>However, the presented results highlight the potential of spatial glycomics-based molecular histology as novel tool for routine diagnostics. We hope that this technical report will be a first steppingstone in this area with MSI based technology combined with dimensionality reduction algorithm.</p>
</sec>
</sec>
<sec sec-type="data-availability" id="sec11">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec12">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Leiden University Medical Center ethical committee. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from a by-product of routine care or industry. Written informed consent for participation was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec13">
<title>Author contributions</title>
<p>FB: conceptualization, data curation, formal analysis, investigation, methodology, software, validation, visualization, writing &#x2013; original draft, and writing &#x2013; review &#x0026; editing. AF-S: conceptualization, data curation, resource, project administration, supervision, and writing &#x2013; review &#x0026; editing. JB: conceptualization, resource, supervision, writing &#x2013; original draft, and writing &#x2013; review &#x0026; editing. BH: conceptualization, data curation, investigation, methodology, project administration, resources, supervision, validation, visualization, and writing &#x2013; review &#x0026; editing. HM: conceptualization, data curation, funding acquisition, methodology, project administration, resources, supervision, validation, and writing &#x2013; review &#x0026; editing. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec14">
<title>Funding</title>
<p>This research is supported by the institutional grant from Leiden University Medical Center funded through legacy of the late Anne Bosma (Leids Universiteits Fonds: 6212). The funding source had no role in the study design, conduct, data analysis and interpretation, or manuscript writing.</p>
</sec>
<ack>
<p>The authors thank Manfred Wuhrer for meaningful discussion on the data, Wenjun Wang and Guinevere S. M. Lageveen-Kammeijer for their expertise in CE-MS analysis and Hans Dalebout and Ren&#x00E9; van Zeijl for excellent technical assistance.</p>
</ack>
<sec sec-type="COI-statement" id="sec15">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec16">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2023.1221553/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmed.2023.1221553/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname> <given-names>NA</given-names></name> <name><surname>Griggs</surname> <given-names>RK</given-names></name></person-group>. <article-title>Bowel cancer screening-generated diagnostic conundrum of the century: pseudoinvasion in sigmoid colonic polyps</article-title>. <source>Mod Pathol</source>. (<year>2015</year>) <volume>28</volume>:<fpage>S88</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1038/modpathol.2014.138</pub-id>, PMID: <pub-id pub-id-type="pmid">25560603</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Backes</surname> <given-names>Y</given-names></name> <name><surname>Moons</surname> <given-names>LMG</given-names></name> <name><surname>Novelli</surname> <given-names>MR</given-names></name> <name><surname>van Bergeijk</surname> <given-names>JD</given-names></name> <name><surname>Groen</surname> <given-names>JN</given-names></name> <name><surname>Seerden</surname> <given-names>TCJ</given-names></name> <etal/></person-group>. <article-title>Diagnosis of T1 colorectal cancer in pedunculated polyps in daily clinical practice: a multicenter study</article-title>. <source>Mod Pathol</source>. (<year>2017</year>) <volume>30</volume>:<fpage>104</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1038/modpathol.2016.165</pub-id>, PMID: <pub-id pub-id-type="pmid">27713422</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holst</surname> <given-names>S</given-names></name> <name><surname>Wuhrer</surname> <given-names>M</given-names></name> <name><surname>Rombouts</surname> <given-names>Y</given-names></name></person-group>. <article-title>Glycosylation characteristics of colorectal cancer</article-title>. <source>Adv Cancer Res</source>. (<year>2015</year>) <volume>126</volume>:<fpage>203</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.acr.2014.11.004</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname> <given-names>JG</given-names></name> <name><surname>Balma&#x00F1;a</surname> <given-names>M</given-names></name> <name><surname>Macedo</surname> <given-names>JA</given-names></name> <name><surname>Po&#x00E7;as</surname> <given-names>J</given-names></name> <name><surname>Fernandes</surname> <given-names>&#x00C2;</given-names></name> <name><surname>JCM</surname> <given-names>D-F-J</given-names></name> <etal/></person-group>. <article-title>Glycosylation in cancer: selected roles in tumour progression, immune modulation and metastasis</article-title>. <source>Cell Immunol</source>. (<year>2018</year>) <volume>333</volume>:<fpage>46</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cellimm.2018.03.007</pub-id>, PMID: <pub-id pub-id-type="pmid">29576316</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Q</given-names></name> <name><surname>Zhan</surname> <given-names>T</given-names></name> <name><surname>Deng</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns</article-title>. <source>Clin Proteomics</source>. (<year>2018</year>) <volume>15</volume>:<fpage>9</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12014-018-9182-4</pub-id>, PMID: <pub-id pub-id-type="pmid">29507546</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Freitas Junior</surname> <given-names>JC</given-names></name> <name><surname>Morgado-D&#x00ED;az</surname> <given-names>JA</given-names></name></person-group>. <article-title>The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications</article-title>. <source>Oncotarget</source>. (<year>2016</year>) <volume>7</volume>:<fpage>19395</fpage>&#x2013;<lpage>413</lpage>. doi: <pub-id pub-id-type="doi">10.18632/oncotarget.6283</pub-id>, PMID: <pub-id pub-id-type="pmid">26539643</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyaval</surname> <given-names>F</given-names></name> <name><surname>van Zeijl</surname> <given-names>R</given-names></name> <name><surname>Dalebout</surname> <given-names>H</given-names></name> <name><surname>Holst</surname> <given-names>S</given-names></name> <name><surname>van Pelt</surname> <given-names>G</given-names></name> <name><surname>Fari&#x00F1;a-Sarasqueta</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>N-Glycomic signature of stage II colorectal Cancer and its association with the tumor microenvironment</article-title>. <source>Mol Cell Proteomics</source>. (<year>2021</year>) <volume>20</volume>:<fpage>100057</fpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.RA120.002215</pub-id>, PMID: <pub-id pub-id-type="pmid">33581319</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyaval</surname> <given-names>F</given-names></name> <name><surname>Dalebout</surname> <given-names>H</given-names></name> <name><surname>Van Zeijl</surname> <given-names>R</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Fari&#x00F1;a-Sarasqueta</surname> <given-names>A</given-names></name> <name><surname>Lageveen-Kammeijer</surname> <given-names>GSM</given-names></name> <etal/></person-group>. <article-title>High-mannose N-Glycans as malignant progression markers in early-stage colorectal Cancer</article-title>. <source>Cancers</source>. (<year>2022</year>) <volume>14</volume>:<fpage>1552</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cancers14061552</pub-id>, PMID: <pub-id pub-id-type="pmid">35326703</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>McDowell</surname> <given-names>CT</given-names></name> <name><surname>Klamer</surname> <given-names>Z</given-names></name> <name><surname>Hall</surname> <given-names>J</given-names></name> <name><surname>West</surname> <given-names>CA</given-names></name> <name><surname>Wisniewski</surname> <given-names>L</given-names></name> <name><surname>Powers</surname> <given-names>TW</given-names></name> <etal/></person-group>. <article-title>Imaging mass spectrometry and lectin analysis of N-linked Glycans in carbohydrate antigen&#x2013;defined pancreatic Cancer tissues</article-title>. <source>Mol Cell Proteomics</source>. (<year>2021</year>) <volume>20</volume>:<fpage>100012</fpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.RA120.002256</pub-id>, PMID: <pub-id pub-id-type="pmid">33581409</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>West</surname> <given-names>CA</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Herrera</surname> <given-names>H</given-names></name> <name><surname>Liang</surname> <given-names>H</given-names></name> <name><surname>Black</surname> <given-names>A</given-names></name> <name><surname>Angel</surname> <given-names>PM</given-names></name> <etal/></person-group>. <article-title>N-linked glycan branching and Fucosylation are increased directly in Hcc tissue as determined through in situ glycan imaging</article-title>. <source>J Proteome Res</source>. (<year>2018</year>) <volume>17</volume>:<fpage>3454</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00323</pub-id>, PMID: <pub-id pub-id-type="pmid">30110170</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Everest-Dass</surname> <given-names>AV</given-names></name> <name><surname>Briggs</surname> <given-names>MT</given-names></name> <name><surname>Kaur</surname> <given-names>G</given-names></name> <name><surname>Oehler</surname> <given-names>MK</given-names></name> <name><surname>Hoffmann</surname> <given-names>P</given-names></name> <name><surname>Packer</surname> <given-names>NH</given-names></name></person-group>. <article-title>N-glycan MALDI imaging mass spectrometry on formalin-fixed paraffin-embedded tissue enables the delineation of ovarian Cancer tissues</article-title>. <source>Mol Cell Proteomics</source>. (<year>2016</year>) <volume>15</volume>:<fpage>3003</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.M116.059816</pub-id>, PMID: <pub-id pub-id-type="pmid">27412689</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>W</given-names></name></person-group>. <article-title>Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal &#x201C;unity of ecology and evolution&#x201D; pathological ecosystem</article-title>. <source>Theranostics</source>. (<year>2023</year>) <volume>13</volume>:<fpage>1607</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.7150/thno.82690</pub-id>, PMID: <pub-id pub-id-type="pmid">37056571</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>McDowell</surname> <given-names>CT</given-names></name> <name><surname>Lu</surname> <given-names>X</given-names></name> <name><surname>Mehta</surname> <given-names>AS</given-names></name> <name><surname>Angel</surname> <given-names>PM</given-names></name> <name><surname>Drake</surname> <given-names>RR</given-names></name></person-group>. <article-title>Applications and continued evolution of glycan imaging mass spectrometry</article-title>. <source>Mass Spectrom Rev</source>. (<year>2023</year>) <volume>42</volume>:<fpage>674</fpage>&#x2013;<lpage>705</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mas.21725</pub-id>, PMID: <pub-id pub-id-type="pmid">34392557</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grgic</surname> <given-names>A</given-names></name> <name><surname>Krestensen</surname> <given-names>KK</given-names></name> <name><surname>Heeren</surname> <given-names>RMA</given-names></name></person-group>. <article-title>Optimized protocol for MALDI MSI of N-glycans using an on-tissue digestion in fresh frozen tissue sections</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>:<fpage>2776</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-023-29560-6</pub-id>, PMID: <pub-id pub-id-type="pmid">36797298</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkinson</surname> <given-names>TR</given-names></name> <name><surname>Clarke</surname> <given-names>HA</given-names></name> <name><surname>Young</surname> <given-names>LEA</given-names></name> <name><surname>Conroy</surname> <given-names>LR</given-names></name> <name><surname>Markussen</surname> <given-names>KH</given-names></name> <name><surname>Kerch</surname> <given-names>KM</given-names></name> <etal/></person-group>. <article-title>In situ spatial glycomic imaging of mouse and human Alzheimer's disease brains</article-title>. <source>Alzheimers Dement</source>. (<year>2022</year>) <volume>18</volume>:<fpage>1721</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alz.12523</pub-id>, PMID: <pub-id pub-id-type="pmid">34908231</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>DelaCourt</surname> <given-names>AT</given-names></name> <name><surname>Liang</surname> <given-names>H</given-names></name> <name><surname>Drake</surname> <given-names>RR</given-names></name> <name><surname>Angel</surname> <given-names>PM</given-names></name> <name><surname>Mehta</surname> <given-names>AS</given-names></name></person-group>. <article-title>Novel combined enzymatic approach to analyze Nonsialylated N-linked Glycans through MALDI imaging mass spectrometry</article-title>. <source>J Proteome Res</source>. (<year>2022</year>) <volume>21</volume>:<fpage>1930</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jproteome.2c00193</pub-id></citation></ref>
</ref-list>
</back>
</article>